-
Precision for Medicine, GmbH CIR (French Research Tax Credit) Accreditation Updates
Discover
-
Precision for Medicine Accelerating Precision Oncology with Next Generation Screening to Support New Cancer Diagnostics
Discover
-
Advaxis Presents Updated Clinical and Immunogenicity Data from Ongoing Phase 1/2 Trial of ADXS-503 in Metastatic Non-Small-Cell Lung Cancer (NSCLC)
Discover
-
Precision for Medicine Receives Top Recognition in CRO Leadership Awards
Discover
-
Deep Lens Announces Launch of Real Time Feasibility Offering to Assist in Oncology Clinical Trial Design and Site Selection
Discover
-
Precision for Medicine Announces Partnership with Trialbee to Expand and Accelerate Clinical Trial Recruitment
Discover
